| Pharmaceutical active ingredients: |
| HydrochlorothiazideLosartan Potassium |
| Available forms, composition and doses of Lorista H: |
| Tablets, Film-Coated; Oral; Hydrochlorothiazide 12.5 mg; Losartan Potassium 50 mg |
| Lorista H medical category: |
| Human:Angiotensin II receptor antagonistsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinationsC09DA01 - Losartan and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| KRKA |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Loar-H | Hydrochlorothiazide; Losartan Potassium | Baroda Pharmaceutical |
| LO-H | Hydrochlorothiazide; Losartan Potassium | East West Pharma |
| Loortan Plus | Hydrochlorothiazide; Losartan Potassium | Therabel Pharma |
| Loplac-D | Hydrochlorothiazide; Losartan Potassium | Casasco Laboratorios |
| Loril-HT | Hydrochlorothiazide; Losartan Potassium | Essweil Pharma |
| Lorista HD | Hydrochlorothiazide; Losartan Potassium | KRKA |
| Lorsar + HCT | Hydrochlorothiazide; Losartan Potassium | Hexal |
| Lortaan Plus | Hydrochlorothiazide; Losartan Potassium | Merck; Medinfar Laboratorio |
| Lorzaar Plus | Hydrochlorothiazide; Losartan Potassium | Merck |
| Lorzan Plus | Hydrochlorothiazide; Losartan Potassium | Clinbaxy International |